IPO registrations (S-1, F-1) · Registrants
Valion Bio, Inc.
- SEC CIK
- 1787740 · filings on EDGAR ↗
- Former names
- Tivic Health Systems, Inc. (2019–2026)
- Registration
- Form S-1, first filed 2021-08-03, last 2026-07-17; 7 initial registrations, 11 amendments
- Outcome
- Final prospectus filed 2021-11-12; declared effective 2021-11-10; withdrawal requested 2026-08-24
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 1305 E. HOUSTON STREET, BUILDING 1, SUITE 311, San Antonio, TX 78205
- EIN
- 81-4016391
- Ticker
- VBIO (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Valion Bio, Inc. on the corporate pages
Offering terms
- Proposed price range
- $5.00–$6.00 per share (S-1/A filed 2021-10-29)
- Final price
- $5.00 per share, within the range (424B4 filed 2021-11-12, an initial public offering)
- Shares sold
- 3,000,000
- Gross proceeds
- $15,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol TIVC
- Lead underwriters
- ThinkEquity
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: VALION BIO, INC. Fuzzy (name and state)
- Form D issuer: Tivic Health Systems, Inc. EXACT (CIK (EXACT))
- SEC filer: Tivic Health Systems, Inc. EXACT (CIK (EXACT))
Filings 37
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2021-08-03 | S-1 | S-1 (registration) | Tivic Health Systems, Inc. | 0001104659-21-099483 ↗ |
| 2021-08-12 | S-1/A | S-1/A (amendment) | Tivic Health Systems, Inc. | 0001104659-21-104099 ↗ |
| 2021-09-09 | S-1/A | S-1/A (amendment) | Tivic Health Systems, Inc. | 0001104659-21-114256 ↗ |
| 2021-09-23 | S-1/A | S-1/A (amendment) | Tivic Health Systems, Inc. | 0001104659-21-118839 ↗ |
| 2021-10-29 | S-1/A | S-1/A (amendment) | Tivic Health Systems, Inc. | 0001104659-21-131885 ↗ |
| 2021-11-10 | EFFECT | EFFECT (declared effective) | Tivic Health Systems, Inc. | 9999999995-21-004277 ↗ |
| 2021-11-12 | 424B4 | 424B4 (final prospectus) | Tivic Health Systems, Inc. | 0001104659-21-137347 ↗ |
| 2022-10-26 | S-1 | S-1 (registration) | Tivic Health Systems, Inc. | 0001193125-22-268956 ↗ |
| 2022-12-09 | S-1/A | S-1/A (amendment) | Tivic Health Systems, Inc. | 0001193125-22-301436 ↗ |
| 2022-12-20 | S-1/A | S-1/A (amendment) | Tivic Health Systems, Inc. | 0001193125-22-309223 ↗ |
| 2023-01-06 | S-1/A | S-1/A (amendment) | Tivic Health Systems, Inc. | 0001193125-23-003081 ↗ |
| 2023-02-01 | S-1/A | S-1/A (amendment) | Tivic Health Systems, Inc. | 0001193125-23-021594 ↗ |
| 2023-02-08 | EFFECT | EFFECT (declared effective) | Tivic Health Systems, Inc. | 9999999995-23-000319 ↗ |
| 2023-02-08 | EFFECT | EFFECT (declared effective) | Tivic Health Systems, Inc. | 9999999995-23-000330 ↗ |
| 2023-02-10 | 424B4 | 424B4 (final prospectus) | Tivic Health Systems, Inc. | 0001193125-23-032652 ↗ |
| 2024-03-29 | S-1 | S-1 (registration) | Tivic Health Systems, Inc. | 0001193125-24-082079 ↗ |
| 2024-04-29 | S-1/A | S-1/A (amendment) | Tivic Health Systems, Inc. | 0001193125-24-119736 ↗ |
| 2024-05-08 | S-1/A | S-1/A (amendment) | Tivic Health Systems, Inc. | 0001193125-24-133716 ↗ |
| 2024-05-09 | EFFECT | EFFECT (declared effective) | Tivic Health Systems, Inc. | 9999999995-24-001454 ↗ |
| 2024-05-13 | 424B4 | 424B4 (final prospectus) | Tivic Health Systems, Inc. | 0001193125-24-136630 ↗ |
| 2025-05-09 | S-1 | S-1 (registration) | Tivic Health Systems, Inc. | 0001683168-25-003353 ↗ |
| 2025-05-13 | EFFECT | EFFECT (declared effective) | Tivic Health Systems, Inc. | 9999999995-25-001569 ↗ |
| 2025-06-06 | S-1 | S-1 (registration) | Tivic Health Systems, Inc. | 0001683168-25-004306 ↗ |
| 2025-07-25 | S-1/A | S-1/A (amendment) | Tivic Health Systems, Inc. | 0001683168-25-005421 ↗ |
| 2025-07-30 | EFFECT | EFFECT (declared effective) | Tivic Health Systems, Inc. | 9999999995-25-002408 ↗ |
| 2025-08-12 | EFFECT | EFFECT (declared effective) | Tivic Health Systems, Inc. | 9999999995-25-002589 ↗ |
| 2025-08-12 | EFFECT | EFFECT (declared effective) | Tivic Health Systems, Inc. | 9999999995-25-002590 ↗ |
| 2025-09-05 | EFFECT | EFFECT (declared effective) | Tivic Health Systems, Inc. | 9999999995-25-002853 ↗ |
| 2026-01-16 | EFFECT | EFFECT (declared effective) | Tivic Health Systems, Inc. | 9999999995-26-000199 ↗ |
| 2026-01-16 | EFFECT | EFFECT (declared effective) | Tivic Health Systems, Inc. | 9999999995-26-000200 ↗ |
| 2026-04-13 | S-1 | S-1 (registration) | Tivic Health Systems, Inc. | 0001683168-26-002867 ↗ |
| 2026-04-15 | EFFECT | EFFECT (declared effective) | Tivic Health Systems, Inc. | 9999999995-26-001207 ↗ |
| 2026-07-17 | S-1 | S-1 (registration) | Valion Bio, Inc. | 0001683168-26-005613 ↗ |
| 2026-08-12 | EFFECT | EFFECT (declared effective) | Valion Bio, Inc. | 9999999995-26-002641 ↗ |
| 2026-08-24 | RW | RW (withdrawal request) | Valion Bio, Inc. | 0001683168-26-006676 ↗ |
| 2026-10-20 | EFFECT | EFFECT (declared effective) | Valion Bio, Inc. | 9999999995-26-003301 ↗ |
| 2026-10-20 | EFFECT | EFFECT (declared effective) | Valion Bio, Inc. | 9999999995-26-003309 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2021-10-29 | S-1/A | registration statement | $5.00–$6.00 | 2,727,272 | - | Nasdaq TIVC | 1 | primary document; range, shares headline, cover names 1 | document ↗ | |
| 2021-11-12 | 424B4 | final prospectus | $5.00 | 3,000,000 | $15,000,000 | Nasdaq TIVC | 1 | primary document; price sentence, shares headline, proceeds table, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Benz Briana | Officer | Chief Financial Officer | 1 | 2021 | |
| Claude John | TenPercentOwner | 1 | 2021 | ||
| Drexler Karen | Director | 8 | 2021–2024 | ||
| Ernst Jennifer | Director,Officer; Director,Officer,TenPercentOwner | Chief Executive Officer | 10 | 2021–2025 | |
| Gurfein Blake | Officer | Chief Scientific Officer | 6 | 2021–2024 | |
| Sabia Ryan | Officer | Chief Operating Officer; VP of Sales and Operations | 4 | 2021–2023 | |
| Zikria Dean | Director; Director,Officer | Interim CEO | 9 | 2021–2026 | |
| Bolton Sheryle | Director | 9 | 2021–2026 | ||
| Cai Veronica | Officer | Chief Financial Officer | 2 | 2022 | |
| Bambach Kimberly Ann | Officer | Interim CFO | 3 | 2023–2024 | |
| Valauri Christina Rizopoulos | Director | 5 | 2024–2026 | ||
| Wolf Lisa G | Officer | Chief Financial Officer; COO & CFO; Interim CFO | 8 | 2024–2026 | |
| Handley Michael K | Director,Officer; Officer | Chief Executive Officer; Chief Operating Officer | 6 | 2025–2026 | |
| Lackey Melinda | Officer | General Counsel & SVP of Legal | 2 | 2026 | |
| Jensen Thomas | Director | 1 | 2026 | ||
| Malbin Jared David | Director | 1 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2025-12-29 | Tivic Health Systems, Inc. | Biotechnology | $75,000,000 | $12,000,000 | 5 | 1 |
| 2025-12-29 | Tivic Health Systems, Inc. | Biotechnology | $16,253,147 | $16,253,147 | 1 | 1 |
| 2019-09-10 | Tivic Health Systems, Inc. | Biotechnology | $9,994,684 | $7,899,667 | 66 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | VALION BIO, INC. | TX | State business registries | name and state |
| Form D issuer | Tivic Health Systems, Inc. | CA | Form D private offerings | CIK (EXACT) |
| SEC filer | Valion Bio, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Valion Bio, Inc. | TX | Trademarks (USPTO) | name and state |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.